m.dalgaard

TL3 Regular · Odense, DK

Health economist by training, which mostly means I am tedious about cost-effectiveness claims.

Joined 26 December 2024 · last posted 1d · groups: journal-club, translators

1 reply marked as the accepted answer.

SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #6 · marked as the solution · Compounds › Tirzepatide · 18 Oct 2025 · 13 likes On post #2 — agreed on the reasoning, with one qualification. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…